-
Symbol
-
LYEL on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001
-
Latest Disclosed Shares Owned
-
1,454,616 shares
-
Security Ownership %
-
7.6%
James B. Tananbaum ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL)
14 Nov 2025 - James B. Tananbaum has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,454,616 shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL).
This represents 7.6% ownership of the company.
This is the first filing by Foresite Capital Fund IV, L.P. disclosing ownership of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL).